Literature DB >> 3480849

The phenotypic frequencies of group specific component and alpha-2-HS-glycoprotein in three ethnic groups. The use of these proteins as racial markers in forensic biology.

S A Westwood1, P J Seaman, C O'Brien, L J Thorogood.   

Abstract

The phenotypic frequencies of group-specific component (Gc) and alpha-2-HS-glycoprotein (A2HS) were determined in White European, Asian and Afro-Caribbean populations. Typical allele frequencies were observed for Gc, with Gc 1S being the major allele for the first two groups and Gc 1F being the major allele for Afro-Caribbeans. For all groups the dominant A2HS allele was A2HS 1, although Asians had a significantly higher proportion of this allele than the White Europeans. Gc and A2HS either singly or in combination with other blood grouping systems provide good discriminating potential. The A2HS 10 allele was detected with a very low frequency in the White European group (A2HS 10 = 0.0013) and was not detected in the Asian group, while the Afro-Caribbean group had a relatively high frequency of this allele (A2HS 10 = 0.0966). The different distribution of the Gc 1F and A2HS 10 alleles in White Europeans and Asians compared with Afro-Caribbeans, can be used to determine the likelihood of blood coming from an Afro-Caribbean.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480849     DOI: 10.1016/0379-0738(87)90056-9

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.

Authors:  Steven J Weintraub; Jacquelyn F Fleckenstein; Tony N Marion; Margaret A Madey; Tahar M Mahmoudi; Kenneth B Schechtman
Journal:  Am J Clin Nutr       Date:  2012-09-26       Impact factor: 7.045

2.  Genetic polymorphism of human alpha 2 HS-glycoprotein (AHSG) in the resident population of the Basque Country (northern Spain).

Authors:  O García; A Alonso
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.